Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Inflammatory Bowel Disease Therapeutics Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Anti-inflammatory Biologics
      • 1.3.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
      • 1.3.4 Corticosteroids
    • 1.4 Market Segment by Application
      • 1.4.1 Global Inflammatory Bowel Disease Therapeutics Market Share by Application (2019-2025)
      • 1.4.2 Solid
      • 1.4.3 Liquid
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Inflammatory Bowel Disease Therapeutics Market Size
      • 2.1.1 Global Inflammatory Bowel Disease Therapeutics Revenue 2014-2025
      • 2.1.2 Global Inflammatory Bowel Disease Therapeutics Sales 2014-2025
    • 2.2 Inflammatory Bowel Disease Therapeutics Growth Rate by Regions
      • 2.2.1 Global Inflammatory Bowel Disease Therapeutics Sales by Regions 2014-2019
      • 2.2.2 Global Inflammatory Bowel Disease Therapeutics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Inflammatory Bowel Disease Therapeutics Sales by Manufacturers
      • 3.1.1 Inflammatory Bowel Disease Therapeutics Sales by Manufacturers 2014-2019
      • 3.1.2 Inflammatory Bowel Disease Therapeutics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Inflammatory Bowel Disease Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Inflammatory Bowel Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Inflammatory Bowel Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Inflammatory Bowel Disease Therapeutics Price by Manufacturers
    • 3.4 Key Manufacturers Inflammatory Bowel Disease Therapeutics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Inflammatory Bowel Disease Therapeutics Market
    • 3.6 Key Manufacturers Inflammatory Bowel Disease Therapeutics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Anti-inflammatory Biologics Sales and Revenue (2014-2019)
      • 4.1.2 Non-Steroidal Anti-inflammatory drugs (NSAIDs) Sales and Revenue (2014-2019)
      • 4.1.3 Corticosteroids Sales and Revenue (2014-2019)
    • 4.2 Global Inflammatory Bowel Disease Therapeutics Sales Market Share by Type
    • 4.3 Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type
    • 4.4 Inflammatory Bowel Disease Therapeutics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Inflammatory Bowel Disease Therapeutics Sales by Application

    6 United States

    • 6.1 United States Inflammatory Bowel Disease Therapeutics Breakdown Data by Company
    • 6.2 United States Inflammatory Bowel Disease Therapeutics Breakdown Data by Type
    • 6.3 United States Inflammatory Bowel Disease Therapeutics Breakdown Data by Application

    7 European Union

    • 7.1 European Union Inflammatory Bowel Disease Therapeutics Breakdown Data by Company
    • 7.2 European Union Inflammatory Bowel Disease Therapeutics Breakdown Data by Type
    • 7.3 European Union Inflammatory Bowel Disease Therapeutics Breakdown Data by Application

    8 China

    • 8.1 China Inflammatory Bowel Disease Therapeutics Breakdown Data by Company
    • 8.2 China Inflammatory Bowel Disease Therapeutics Breakdown Data by Type
    • 8.3 China Inflammatory Bowel Disease Therapeutics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Inflammatory Bowel Disease Therapeutics Breakdown Data by Company
    • 9.2 Rest of World Inflammatory Bowel Disease Therapeutics Breakdown Data by Type
    • 9.3 Rest of World Inflammatory Bowel Disease Therapeutics Breakdown Data by Application
    • 9.4 Rest of World Inflammatory Bowel Disease Therapeutics Breakdown Data by Countries
      • 9.4.1 Rest of World Inflammatory Bowel Disease Therapeutics Sales by Countries
      • 9.4.2 Rest of World Inflammatory Bowel Disease Therapeutics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Abbvie
      • 10.1.1 Abbvie Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Inflammatory Bowel Disease Therapeutics
      • 10.1.4 Inflammatory Bowel Disease Therapeutics Product Introduction
      • 10.1.5 Abbvie Recent Development
    • 10.2 Johnson & Johnson
      • 10.2.1 Johnson & Johnson Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Inflammatory Bowel Disease Therapeutics
      • 10.2.4 Inflammatory Bowel Disease Therapeutics Product Introduction
      • 10.2.5 Johnson & Johnson Recent Development
    • 10.3 GlaxoSmithKline
      • 10.3.1 GlaxoSmithKline Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Inflammatory Bowel Disease Therapeutics
      • 10.3.4 Inflammatory Bowel Disease Therapeutics Product Introduction
      • 10.3.5 GlaxoSmithKline Recent Development
    • 10.4 Merck
      • 10.4.1 Merck Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Inflammatory Bowel Disease Therapeutics
      • 10.4.4 Inflammatory Bowel Disease Therapeutics Product Introduction
      • 10.4.5 Merck Recent Development
    • 10.5 Novartis
      • 10.5.1 Novartis Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Inflammatory Bowel Disease Therapeutics
      • 10.5.4 Inflammatory Bowel Disease Therapeutics Product Introduction
      • 10.5.5 Novartis Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Inflammatory Bowel Disease Therapeutics Sales Channels
      • 11.2.2 Inflammatory Bowel Disease Therapeutics Distributors
    • 11.3 Inflammatory Bowel Disease Therapeutics Customers

    12 Market Forecast

    • 12.1 Global Inflammatory Bowel Disease Therapeutics Sales and Revenue Forecast 2019-2025
    • 12.2 Global Inflammatory Bowel Disease Therapeutics Sales Forecast by Type
    • 12.3 Global Inflammatory Bowel Disease Therapeutics Sales Forecast by Application
    • 12.4 Inflammatory Bowel Disease Therapeutics Forecast by Regions
      • 12.4.1 Global Inflammatory Bowel Disease Therapeutics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Inflammatory Bowel Disease Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Inflammatory bowel disease (IBD) is a broad term used to describe disorders involving chronic inflammation of digestive tract. The disease is categorized by severe diarrhea, abdominal pain, fatigue, and weight loss.
      Increase in incidences of IBD and rise in adoption of anti-inflammatory drugs drive the market.  
      In addition, strong upcoming pipeline of IBD drugs also boosts the market growth.
      However, side effects of these drugs over a patients body restrain the market growth.
      In 2019, the market size of Inflammatory Bowel Disease Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Inflammatory Bowel Disease Therapeutics.

      This report studies the global market size of Inflammatory Bowel Disease Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Inflammatory Bowel Disease Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbvie
      Johnson & Johnson
      GlaxoSmithKline
      Merck
      Novartis
      ...

      Market Segment by Product Type
      Anti-inflammatory Biologics
      Non-Steroidal Anti-inflammatory drugs (NSAIDs)
      Corticosteroids

      Market Segment by Application
      Solid
      Liquid

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Inflammatory Bowel Disease Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Inflammatory Bowel Disease Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Inflammatory Bowel Disease Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now